NO305314B1 - N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonister - Google Patents
N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonisterInfo
- Publication number
- NO305314B1 NO305314B1 NO941820A NO941820A NO305314B1 NO 305314 B1 NO305314 B1 NO 305314B1 NO 941820 A NO941820 A NO 941820A NO 941820 A NO941820 A NO 941820A NO 305314 B1 NO305314 B1 NO 305314B1
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- tritylaspartic
- acid derivatives
- nmda antagonists
- phosphonate
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- KGMHYPXNXMMYOA-FQEVSTJZSA-N (2s)-2-(tritylamino)butanedioic acid Chemical class C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@@H](CC(=O)O)C(O)=O)C1=CC=CC=C1 KGMHYPXNXMMYOA-FQEVSTJZSA-N 0.000 title 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 title 1
- HYHXAZMLKDGXEI-JOCHJYFZSA-N dimethyl (2r)-2-(tritylamino)butanedioate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@H](CC(=O)OC)C(=O)OC)C1=CC=CC=C1 HYHXAZMLKDGXEI-JOCHJYFZSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79283491A | 1991-11-15 | 1991-11-15 | |
| PCT/US1992/008739 WO1993010075A1 (en) | 1991-11-15 | 1992-10-13 | N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO941820D0 NO941820D0 (no) | 1994-05-13 |
| NO941820L NO941820L (no) | 1994-05-13 |
| NO305314B1 true NO305314B1 (no) | 1999-05-10 |
Family
ID=25158215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941820A NO305314B1 (no) | 1991-11-15 | 1994-05-13 | N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonister |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0613459B1 (hu) |
| JP (1) | JP3168563B2 (hu) |
| KR (1) | KR100241480B1 (hu) |
| AT (1) | ATE134989T1 (hu) |
| AU (1) | AU667845B2 (hu) |
| CA (1) | CA2121835A1 (hu) |
| DE (1) | DE69208888T2 (hu) |
| DK (1) | DK0613459T3 (hu) |
| ES (1) | ES2087555T3 (hu) |
| FI (1) | FI942248A0 (hu) |
| GR (1) | GR3019587T3 (hu) |
| HU (1) | HU214055B (hu) |
| IL (1) | IL103710A (hu) |
| MX (1) | MX9206448A (hu) |
| NO (1) | NO305314B1 (hu) |
| WO (1) | WO1993010075A1 (hu) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU632362B2 (en) * | 1989-09-19 | 1992-12-24 | Merrell Dow Pharmaceuticals Inc. | Nmda antagonists |
-
1992
- 1992-10-13 EP EP92921774A patent/EP0613459B1/en not_active Expired - Lifetime
- 1992-10-13 HU HU9401469A patent/HU214055B/hu not_active IP Right Cessation
- 1992-10-13 DK DK92921774.3T patent/DK0613459T3/da active
- 1992-10-13 CA CA002121835A patent/CA2121835A1/en not_active Abandoned
- 1992-10-13 ES ES92921774T patent/ES2087555T3/es not_active Expired - Lifetime
- 1992-10-13 DE DE69208888T patent/DE69208888T2/de not_active Expired - Fee Related
- 1992-10-13 KR KR1019940701634A patent/KR100241480B1/ko not_active IP Right Cessation
- 1992-10-13 JP JP50924593A patent/JP3168563B2/ja not_active Expired - Fee Related
- 1992-10-13 AT AT92921774T patent/ATE134989T1/de not_active IP Right Cessation
- 1992-10-13 AU AU28642/92A patent/AU667845B2/en not_active Ceased
- 1992-10-13 WO PCT/US1992/008739 patent/WO1993010075A1/en active IP Right Grant
- 1992-11-10 MX MX9206448A patent/MX9206448A/es not_active IP Right Cessation
- 1992-11-11 IL IL103710A patent/IL103710A/en not_active IP Right Cessation
-
1994
- 1994-05-13 FI FI942248A patent/FI942248A0/fi unknown
- 1994-05-13 NO NO941820A patent/NO305314B1/no not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960400979T patent/GR3019587T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69208888D1 (de) | 1996-04-11 |
| HU214055B (en) | 1997-12-29 |
| NO941820D0 (no) | 1994-05-13 |
| EP0613459A1 (en) | 1994-09-07 |
| HUT70551A (en) | 1995-10-30 |
| EP0613459B1 (en) | 1996-03-06 |
| AU667845B2 (en) | 1996-04-18 |
| CA2121835A1 (en) | 1993-05-27 |
| JPH07501523A (ja) | 1995-02-16 |
| FI942248A (fi) | 1994-05-13 |
| WO1993010075A1 (en) | 1993-05-27 |
| IL103710A (en) | 1998-02-08 |
| FI942248A0 (fi) | 1994-05-13 |
| DE69208888T2 (de) | 1996-08-01 |
| ES2087555T3 (es) | 1996-07-16 |
| AU2864292A (en) | 1993-06-15 |
| IL103710A0 (en) | 1993-04-04 |
| JP3168563B2 (ja) | 2001-05-21 |
| NO941820L (no) | 1994-05-13 |
| KR100241480B1 (ko) | 2000-03-02 |
| ATE134989T1 (de) | 1996-03-15 |
| GR3019587T3 (en) | 1996-07-31 |
| HU9401469D0 (en) | 1994-08-29 |
| DK0613459T3 (da) | 1996-04-01 |
| MX9206448A (es) | 1993-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO905608L (no) | Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater. | |
| NO914429L (no) | Fremgangsmaate for fremstilling av piperidinylkamfersulfonyloxytocin-antagonister | |
| ES2078257T3 (es) | Antagonistas de aminoacidos excitantes. | |
| ES2088011T3 (es) | Antagonistas de aminoacidos excitadores. | |
| NO884590D0 (no) | Fremgangsmaate for fremstilling av trelagspapir. | |
| ATE79637T1 (de) | Substituierte alkylamide von teicoplaninverbindungen. | |
| ES2072607T3 (es) | Derivados 3 indolil tioacetato. | |
| TR23816A (tr) | Fosfatsiz agartici deterjan bilesimleri | |
| NO167980C (no) | Analogifremgangsmaate for fremstilling av tienoimidazol-derivater. | |
| NO305314B1 (no) | N-tritylasparaginsyrederivater samt fremstilling av fosfonat-NMDA-antagonister | |
| ES2089511T3 (es) | Dihidroquinolina antagonistas de nmda. | |
| GR1001566B (el) | Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης. | |
| ES2032209T3 (es) | Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen. | |
| NO171161C (no) | Fremgangsmaate for fremstilling av substituerte benzotiopyrano (4,3,2-cd)indazoler | |
| IT8921129A0 (it) | Procedimento per la preparazione di n fosfonometilglicina. | |
| ITMI912138A0 (it) | Procedimento per la preparazione di fosfatidi | |
| FI872340A0 (fi) | Anordning foer insprutning av avlut i en kemikalieaotervinningsugn. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN APRIL 2001 |